Centurylink Investment Management Co adds Baxter International Inc (BAX) to its portfolio

Baxter International Inc (BAX) : Centurylink Investment Management Co added new position in Baxter International Inc during the most recent quarter end. The investment management firm now holds 38,074 shares of Baxter International Inc which is valued at $1,789,859 , the company said in a statement filed on Oct 12, 2016 with the SEC.Baxter International Inc makes up approximately 0.62% of Centurylink Investment Management Co’s portfolio.

Other Hedge Funds, Including , Canandaigua National Bank Trust Co reduced its stake in BAX by selling 5 shares or 0.04% in the most recent quarter. The Hedge Fund company now holds 11,622 shares of BAX which is valued at $546,350. Baxter International Inc makes up approx 0.16% of Canandaigua National Bank Trust Co’s portfolio.Oregon Public Employees Retirement Fund boosted its stake in BAX in the latest quarter, The investment management firm added 3,640 additional shares and now holds a total of 136,553 shares of Baxter International Inc which is valued at $6,595,510. Baxter International Inc makes up approx 0.14% of Oregon Public Employees Retirement Fund’s portfolio.Advisory Services Network boosted its stake in BAX in the latest quarter, The investment management firm added 615 additional shares and now holds a total of 1,348 shares of Baxter International Inc which is valued at $65,311. Baxter International Inc makes up approx 0.01% of Advisory Services Network’s portfolio.Bnp Paribas Arbitrage Sa reduced its stake in BAX by selling 2,223,042 shares or 97.46% in the most recent quarter. The Hedge Fund company now holds 57,988 shares of BAX which is valued at $2,778,785. Baxter International Inc makes up approx 0.01% of Bnp Paribas Arbitrage Sa’s portfolio.West Oak Capital boosted its stake in BAX in the latest quarter, The investment management firm added 1,400 additional shares and now holds a total of 6,049 shares of Baxter International Inc which is valued at $289,868. Baxter International Inc makes up approx 0.20% of West Oak Capital’s portfolio.

Baxter International Inc closed down -1.29 points or -2.67% at $47.01 with 28,86,483 shares getting traded on Tuesday. Post opening the session at $48.14, the shares hit an intraday low of $46.7 and an intraday high of $48.17 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Baxter International Inc reported $0.46 EPS for the quarter, beating the analyst consensus estimate by $ 0.06 according to the earnings call on Jul 26, 2016. Analyst had a consensus of $0.40. The company had revenue of $2585.00 million for the quarter, compared to analysts expectations of $2516.16 million. The company’s revenue was up 4.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.00 EPS.

Many Wall Street Analysts have commented on Baxter International Inc. Baxter International Inc was Initiated by Wells Fargo to “Outperform” on Oct 13, 2016. Company shares were Reiterated by RBC Capital Mkts on Jul 27, 2016 to “Sector Perform”, Firm has raised the Price Target to $ 50 from a previous price target of $47 .

Baxter International Inc. (Baxter) is a diversified healthcare company. The Company operates in two segments: BioScience segment which include three commercial franchises: Hemophilia BioTherapeutics and BioSurgery and Medical Products segment which include four commercial franchises: Fluid Systems Renal Specialty Pharmaceuticals and BioPharma Solutions. Its BioScience processes recombinant and plasma-based proteins to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies alpha-1 antitrypsin deficiency burns and shock and other chronic and acute blood-related conditions and biosurgery products. Its Medical Products manufactures intravenous (IV) solutions and administration sets premixed drugs and drug-reconstitution systems pre-filled vials and syringes for injectable drugs IV nutrition products infusion pumps and inhalation anesthetics. Its products are used in hospitals kidney dialysis centers and nursing homes among others.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Baxter International Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Baxter International Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.